Cargando…
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma
DNA vaccine can be modified to increase protein production and modulate immune response. To enhance the efficiency of a P815 mastocytoma DNA vaccine, the P1A gene sequence was optimized by substituting specific codons with synonymous ones while modulating the number of CpG motifs. The P815A murine a...
Autores principales: | Lopes, Alessandra, Vanvarenberg, Kevin, Préat, Véronique, Vandermeulen, Gaëlle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537203/ https://www.ncbi.nlm.nih.gov/pubmed/28918040 http://dx.doi.org/10.1016/j.omtn.2017.07.011 |
Ejemplares similares
-
Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
por: Lopes, Alessandra, et al.
Publicado: (2018) -
Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
por: Bausart, Mathilde, et al.
Publicado: (2022) -
Role of microvilli in surface changes of synchronized P815Y mastocytoma cells
Publicado: (1975) -
T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases
Publicado: (1981) -
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice
Publicado: (1980)